608 related articles for article (PubMed ID: 7694807)
1. Monoclonal anti-CD44 antibody acts in synergy with anti-CD2 but inhibits anti-CD3 or T cell receptor-mediated signaling in murine T cell hybridomas.
Guo YJ; Ma J; Wong JH; Lin SC; Chang HC; Bigby M; Sy MS
Cell Immunol; 1993 Nov; 152(1):186-99. PubMed ID: 7694807
[TBL] [Abstract][Full Text] [Related]
2. Antibodies against the CD44 p80, lymphocyte homing receptor molecule augment human peripheral blood T cell activation.
Denning SM; Le PT; Singer KH; Haynes BF
J Immunol; 1990 Jan; 144(1):7-15. PubMed ID: 1967267
[TBL] [Abstract][Full Text] [Related]
3. CD44 contributes to T cell activation.
Huet S; Groux H; Caillou B; Valentin H; Prieur AM; Bernard A
J Immunol; 1989 Aug; 143(3):798-801. PubMed ID: 2568380
[TBL] [Abstract][Full Text] [Related]
4. Modulation of TCR-mediated signaling pathway by thymic shared antigen-1 (TSA-1)/stem cell antigen-2 (Sca-2).
Saitoh S; Kosugi A; Noda S; Yamamoto N; Ogata M; Minami Y; Miyake K; Hamaoka T
J Immunol; 1995 Dec; 155(12):5574-81. PubMed ID: 7499840
[TBL] [Abstract][Full Text] [Related]
5. Human T cell activation by OKT3 is inhibited by a monoclonal antibody to CD44.
Rothman BL; Blue ML; Kelley KA; Wunderlich D; Mierz DV; Aune TM
J Immunol; 1991 Oct; 147(8):2493-9. PubMed ID: 1833455
[TBL] [Abstract][Full Text] [Related]
6. Analysis of CD4 and CD2 receptor function.
Goldman SJ; Bierer BE; Burakoff SJ
Princess Takamatsu Symp; 1988; 19():149-60. PubMed ID: 2908352
[TBL] [Abstract][Full Text] [Related]
7. Induction of negative signal through CD2 during antigen-specific T cell activation.
Ohno H; Nakamura T; Yagita H; Okumura K; Taniguchi M; Saito T
J Immunol; 1991 Oct; 147(7):2100-6. PubMed ID: 1680913
[TBL] [Abstract][Full Text] [Related]
8. Interaction of CD2 with its ligand lymphocyte function-associated antigen-3 induces adenosine 3',5'-cyclic monophosphate production in T lymphocytes.
Hahn WC; Rosenstein Y; Burakoff SJ; Bierer BE
J Immunol; 1991 Jul; 147(1):14-21. PubMed ID: 1711070
[TBL] [Abstract][Full Text] [Related]
9. Activation of cord T lymphocytes. I. Evidence for a defective T cell mitogenesis induced through the CD2 molecule.
Gerli R; Bertotto A; Crupi S; Arcangeli C; Marinelli I; Spinozzi F; Cernetti C; Angelella P; Rambotti P
J Immunol; 1989 Apr; 142(8):2583-9. PubMed ID: 2564856
[TBL] [Abstract][Full Text] [Related]
10. Differences in the stimulating capacity of immobilized anti-CD3 monoclonal antibodies: variable dependence on interleukin-1 as a helper signal for T-cell activation.
Verwilghen J; Baroja ML; Van Vaeck F; Van Damme J; Ceuppens JL
Immunology; 1991 Feb; 72(2):269-76. PubMed ID: 1826671
[TBL] [Abstract][Full Text] [Related]
11. Anti-CD2 monoclonal antibody-induced receptor changes: down modulation of cell surface CD2.
Lin J; Yon RW; Chavin KD; Qin L; Woodward J; Ding Y; Yagita H; Bromberg JS
Transplantation; 1995 Apr; 59(8):1162-71. PubMed ID: 7537394
[TBL] [Abstract][Full Text] [Related]
12. CD2-mediated adhesion facilitates T lymphocyte antigen recognition function.
Moingeon P; Chang HC; Wallner BP; Stebbins C; Frey AZ; Reinherz EL
Nature; 1989 May; 339(6222):312-4. PubMed ID: 2566919
[TBL] [Abstract][Full Text] [Related]
13. A common pathway for T lymphocyte activation involving both the CD3-Ti complex and CD2 sheep erythrocyte receptor determinants.
Yang SY; Chouaib S; Dupont B
J Immunol; 1986 Aug; 137(4):1097-100. PubMed ID: 2426350
[TBL] [Abstract][Full Text] [Related]
14. Inhibition of transformed T cell growth in vitro by monoclonal antibodies directed against distinct activating molecules.
Merćep M; Bluestone JA; Noguchi PD; Ashwell JD
J Immunol; 1988 Jan; 140(1):324-35. PubMed ID: 2891766
[TBL] [Abstract][Full Text] [Related]
15. Use of I region-restricted, antigen-specific T cell hybridomas to produce idiotypically specific anti-receptor antibodies.
White J; Haskins KM; Marrack P; Kappler J
J Immunol; 1983 Mar; 130(3):1033-7. PubMed ID: 6185566
[TBL] [Abstract][Full Text] [Related]
16. CD44 antibody against In(Lu)-related p80, lymphocyte-homing receptor molecule inhibits the binding of human erythrocytes to T cells.
Hale LP; Singer KH; Haynes BF
J Immunol; 1989 Dec; 143(12):3944-8. PubMed ID: 2480381
[TBL] [Abstract][Full Text] [Related]
17. Uncoupling IL-2 production from apoptosis and TNF production by changing the signal through the TCR.
Glickstein L; Macphail S; Stutman O
J Immunol; 1996 Mar; 156(6):2062-7. PubMed ID: 8690893
[TBL] [Abstract][Full Text] [Related]
18. Elevation of intracellular cAMP in human T lymphocytes by an anti-CD44 mAb.
Rothman BL; Kennure N; Kelley KA; Katz M; Aune TM
J Immunol; 1993 Dec; 151(11):6036-42. PubMed ID: 7504012
[TBL] [Abstract][Full Text] [Related]
19. Evidences for protein kinase C. Activation in T lymphocytes by stimulation of either the CD2 or CD3 antigens.
Friedrich B; Cantrell DA; Gullberg M
Eur J Immunol; 1989 Jan; 19(1):17-23. PubMed ID: 2563972
[TBL] [Abstract][Full Text] [Related]
20. sgp-60, a signal-transducing glycoprotein concerned with T cell activation through the T cell receptor/CD3 complex.
Reiser H
J Immunol; 1990 Oct; 145(7):2077-86. PubMed ID: 1975823
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
